Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

被引：2
|
作者：
Sharma, Ashish [1 ,6 ]
Loewenstein, Anat [2 ]
Parachuri, Nikulaa [3 ]
Kumar, Nilesh [4 ]
Kuppermann, Baruch D. [5 ]
机构：
[1] Lotus Eye Hosp & Inst, Coimbatore, TN, India
[2] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Ophthalmol, Tel Aviv, Israel
[3] Sankara Eye Hosp, Dept Vitreoretina, Coimbatore, TN, India
[4] Madhavi Netralaya, Ara, Bihar, India
[5] Univ Calif Irvine, Gavin Herbert Eye Inst, Dept Ophthalmol, Irvine, CA USA
[6] Lotus Eye Hosp & Inst, Avinashi Rd, Coimbatore 641014, TN, India
来源：
JOURNAL OF VITREORETINAL DISEASES | 2023年 / 7卷 / 06期
关键词：
biosimilar; switch; retina; anti-VEGF;
D O I：
10.1177/24741264231202080
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：474 / 476
页数：3
相关论文
共 50 条
  • [1] Biosimilar anti-VEGF—Yardsticks to ensure biosimilarity
    Ashish Sharma
    Nikulaa Parachuri
    Nilesh Kumar
    Francesco Bandello
    Baruch D. Kuppermann
    Eye, 2023, 37 : 4 - 5
  • [2] Fear of safety compromise with biosimilar anti-VEGF—perception or truth
    Ashish Sharma
    Nikulaa Parachuri
    Nilesh Kumar
    Francesco Bandello
    Baruch D. Kuppermann
    Eye, 2022, 36 : 2086 - 2087
  • [3] Anti-VEGF for ROP and Pediatric Retinal Diseases
    Wu, An-Lun
    Wu, Wei-Chi
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2018, 7 (03): : 145 - 151
  • [4] The Biosimilar Paradox: How Anti-VEGF Biosimilars will Increase Patient and Overall Healthcare Costs
    Zhang, Casey
    Friedman, Scott
    Mruthyunjaya, Prithvi
    Parikh, Ravi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [5] Aflibercept 2 mg biosimilars-will they lead the Anti-VEGF biosimilar world globally
    Sharma, Ashish
    Woo, Se Joon
    Lee, Christopher Seungkyu
    Kumar, Nilesh
    Parachuri, Nikulaa
    Bandello, Francesco
    Loewenstein, Anat
    Kuppermann, Baruch D.
    EYE, 2025, 39 (06) : 1026 - 1027
  • [6] VEGF, anti-VEGF and diseases
    Corvol, Pierre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2008, 192 (02): : 289 - 302
  • [7] ANTI-VEGF MOLECULE UTILIZATION IN OPHTHALMOLOGY AND POTENTIAL IMPACT OF MARKET DYNAMICS AFTER BIOSIMILAR ENTRY
    Xin, Q.
    Grieco, S.
    Biernacka, K.
    Bodin, M.
    VALUE IN HEALTH, 2024, 27 (06) : S219 - S219
  • [8] THE IBD BIOSIMILAR TO BIOSIMILAR SWITCHING STUDY (IBISS)
    Harris, Clare
    Harris, Richard James
    Young, David
    McDonnell, Martin
    Clancy, Bridget
    Harvey, Justin
    Latter, Susan
    Cummings, Fraser
    GUT, 2021, 70 : A87 - A87
  • [9] Anti-VEGF and Retinal Dystrophies
    Parodi, Maurizio Battaglia
    Iacono, Pierluigi
    Da Pozzo, Stefano
    CURRENT DRUG TARGETS, 2020, 21 (12) : 1201 - 1207
  • [10] Biosimilar anti-VEGF-Yardsticks to ensure biosimilarity
    Sharma, Ashish
    Parachuri, Nikulaa
    Kumar, Nilesh
    Bandello, Francesco
    Kuppermann, Baruch D.
    EYE, 2023, 37 (01) : 4 - 5
12345